Identification and frequency of the rs12516 and rs8176318 BRCA1 gene polymorphisms among different populations

Yang,Fang; Chen,Fengxia; Xu,Jin; Guan,Xiaoxiang

doi:10.3892/ol.2016.4252

Identification and frequency of the rs12516 and rs8176318 BRCA1 gene polymorphisms among different populations

Authors:
- Fang Yang
- Fengxia Chen
- Jin Xu
- Xiaoxiang Guan
View Affiliations

Affiliations: Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, P.R. China
Published online on: February 19, 2016 https://doi.org/10.3892/ol.2016.4252
Pages: 2481-2486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genetic mutation of breast cancer 1 (BRCA1) is one of the most notable factors responsible for a proportion of breast cancer cases. BRCA1 encodes a 1,863‑amino acid protein and functions as a negative regulator of tumor growth. Thus, investigation of the underlying mechanisms that regulate BRCA1 gene expression provide further insight into possible targets for breast cancer therapy. Previous studies have demonstrated that the genetic variants in the BRCA1 3' untranslated region (3'UTR), in addition to the cytosine‑phosphate‑guanine (CpG) islands in the promoter region, are significantly associated with breast cancer risk; however, the role of single nucleotide polymorphisms (SNPs) in the BRCA1 3'UTR remains unclear. The present study aimed to investigate the association between SNPs and BRCA1 mRNA expression levels. Bioinformatics analysis demonstrated that 2 SNPs in the BRCA1 3'UTR (rs12516 and rs8176318 with putative microRNA binding sites) were significantly correlated with mRNA expression in lymphoblastoid cell lines (P=2.55x10‑4 and P=8.78x10‑5, respectively). Furthermore, the genotype frequency distribution varied between populations worldwide. In addition, 3 CpG islands and several transcription factor binding sites in the BRCA1 promoter region were established. The identification of such polymorphisms and CpG islands may aid in designing improved therapeutic strategies to treat patients with BRCA1-associated breast cancer.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ayoub N, Lucas C and Kaddoumi A: Genomics and pharmacogenomics of breast cancer: Current knowledge and trends. Asian Pac J Cancer Prev. 12:1127–1140. 2011.PubMed/NCBI
3	Zeisberg EM and Zeisberg M: The role of promoter hypermethylation in fibroblast activation and fibrogenesis. J Pathol. 229:264–273. 2013. View Article : Google Scholar : PubMed/NCBI
4	Hook L, Hancock M, Landais I, Grabski R, Britt W and Nelson JA: Cytomegalovirus microRNAs. Curr Opin Virol. 7:40–46. 2014. View Article : Google Scholar : PubMed/NCBI
5	Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB and Zhao H: A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 29:1963–1966. 2008. View Article : Google Scholar : PubMed/NCBI
6	Holm K, Melum E, Franke A and Karlsen TH: SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics. 11:6002010. View Article : Google Scholar : PubMed/NCBI
7	International HapMap Consortium: The International HapMap Project. Nature. 426:789–796. 2003. View Article : Google Scholar : PubMed/NCBI
8	Pelletier C, Speed WC, Paranjape T, Keane K, Blitzblau R, Hollestelle A, Safavi K, van den Ouweland A, Zelterman D, Slack FJ, et al: Rare BRCA1 haplotypes including 3′UTR SNPs associated with breast cancer risk. Cell Cycle. 10:90–99. 2011. View Article : Google Scholar : PubMed/NCBI
9	Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J and Lenoir GM: Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet. 338:82–83. 1991. View Article : Google Scholar : PubMed/NCBI
10	Yang ES and Xia F: BRCA1 16 years later: DNA damage-induced BRCA1 shuttling. FEBS J. 277:3079–3085. 2010. View Article : Google Scholar : PubMed/NCBI
11	Dacheux E, Vincent A, Nazaret N, Combet C, Wierinckx A, Mazoyer S, Diaz JJ, Lachuer J and Venezia ND: BRCA1-Dependent Translational Regulation in Breast Cancer Cells. PLoS One. 8:e673132013. View Article : Google Scholar : PubMed/NCBI
12	Williamson EA, Dadmanesh F and Koeffler HP: BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene. 21:3199–3206. 2002. View Article : Google Scholar : PubMed/NCBI
13	Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y and Noguchi S: BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res Treat. 129:69–77. 2011. View Article : Google Scholar : PubMed/NCBI
14	Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, et al: BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat. 115:397–404. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hsu NC, Huang YF, Yokoyama KK, Chu PY, Chen FM and Hou MF: Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. PLoS One. 8:e562562013. View Article : Google Scholar : PubMed/NCBI
16	Wu L, Wang F, Xu R, Zhang S, Peng X, Feng Y, Wang J and Lu C: Promoter methylation of BRCA1 in the prognosis of breast cancer: A meta-analysis. Breast Cancer Res Treat. 142:619–627. 2013. View Article : Google Scholar : PubMed/NCBI
17	Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O, et al: miR-24 Inhibits cell proliferation by targeting E2F2, MYC and other cell-cycle genes via binding to ‘seedless’ 3′UTR microRNA recognition elements. Mol Cell. 35:610–625. 2009. View Article : Google Scholar : PubMed/NCBI
18	Huo X, Lu C, Huang X, Hu Z, Jin G, Ma H, Wang X, Qin J, Wang X, Shen H and Tang J: Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol. 135:1569–1575. 2009. View Article : Google Scholar : PubMed/NCBI
19	Hasan TN, Shafi G, Syed NA, Alsaif MA, Alsaif AA and Alshatwi AA: Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area. Asian Pac J Cancer Prev. 14:5671–5674. 2013. View Article : Google Scholar : PubMed/NCBI